Lymphocytes in atherosclerosis

Clinica Chimica Acta; International Journal of Clinical Chemistry
Maria WigrenDaniel Kolbus

Abstract

It is well established that atherosclerosis is caused by an inflammatory process in the arterial intima. However, it is only in recent years that it has become clear that this inflammation is modulated by immune responses against plaque antigens. These antigens are primarily believed to be modified self-antigens such as oxidized LDL. The immune system is challenged to determine whether these antigens should be regarded self and tolerated or non-self and eliminated. The latter will result in plaque development while the first will be protective. T cells are key effectors of both types of responses. An activation of regulatory T cells inhibits auto-reactive T effector cells and is anti-inflammatory. In contrast, if Th1 cells become activated in the plaque this is associated with increased inflammation and disease progression. The role of B cells in atherosclerosis remains to be clarified but some species of athero-protective antibodies have been identified. The elucidation of role of immune system in atherosclerosis has revealed new targets for intervention and both vaccines and antibody-based therapies are presently in or due to enter clinical testing.

References

Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·S StemmeG K Hansson
Dec 1, 1994·The Journal of Clinical Investigation·A I FyfeA J Lusis
Sep 3, 1998·The Journal of Clinical Investigation·A NicolettiG K Hansson
Oct 16, 1999·Circulation Research·Z MallatA Tedgui
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·B LudewigH Hengartner
Sep 8, 2001·Stroke; a Journal of Cerebral Circulation·Z G NadareishviliT J DeGraba
Jul 16, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Zuyi YuanMasayuki Yokode
Aug 26, 2003·The American Journal of Pathology·Piers Davenport, Peter G Tipping
Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jaime LlodráGwendalyn J Randolph
Sep 14, 2004·Current Opinion in Lipidology·Jan Nilsson, Petri T Kovanen
Jan 22, 2005·Circulation Research·Xinghua ZhouGöran K Hansson
Jan 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Chiara BuonoAndrew H Lichtman
Feb 8, 2006·Nature Medicine·Hafid Ait-OufellaZiad Mallat
Aug 9, 2006·The Journal of Experimental Medicine·Jenny Jongstra-BilenMyron I Cybulsky
Aug 30, 2006·Scandinavian Journal of Infectious Diseases·Christina Nyström-RosanderGöran Friman
May 29, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Marzena DworackaGrzegorz Dworacki
Sep 15, 2007·The Journal of Clinical Investigation·Israel GotsmanAndrew H Lichtman
Nov 22, 2007·Atherosclerosis·Nicole BorelAndreas Pospischil
Feb 13, 2008·The Journal of Experimental Medicine·Ashley M MillerFoo Y Liew
Apr 16, 2008·Journal of Internal Medicine·J Nilsson, G K Hansson
May 20, 2008·Cardiovascular Research·Robert KleemannTeake Kooistra
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Aug 19, 2008·Human Pathology·Jan GewaltigBarbara C Biedermann
Sep 25, 2008·Human Immunology·Masakatsu SuzukiCornelia M Weyand
Apr 18, 2009·Microbes and Infection·Pierre Miossec
Jul 18, 2009·European Journal of Immunology·Zhe ShiHaruhiko Suzuki
Aug 8, 2009·Biochemical and Biophysical Research Communications·T van EsJ Kuiper
Sep 10, 2009·The Journal of Experimental Medicine·Soraya TalebZiad Mallat
Sep 16, 2009·Scandinavian Journal of Immunology·A Corthay

❮ Previous
Next ❯

Citations

Apr 29, 2014·Human Immunology·Amy H Newton, Stephen H Benedict
Nov 1, 2015·Cellular and Molecular Life Sciences : CMLS·Charlotte SpitzNorbert Gerdes
Dec 3, 2014·Atherosclerosis·Alexandra V PotekhinaTatiana Arefieva
Jan 15, 2015·Atherosclerosis·Angela SilveiraAnders Hamsten
Jun 29, 2016·Clinical & Translational Immunology·Michael J KraakmanAndrew J Murphy
May 14, 2016·Annals of Human Biology·Aaron D BlackwellMichael Gurven
Sep 27, 2016·Evolution, Medicine, and Public Health·Michael D GurvenHillard S Kaplan
Jun 8, 2013·Circulation Research·Hiroshi IwataRyozo Nagai
Apr 17, 2015·World Journal of Clinical Cases·Fulya Ilhan, Sevgi Tas Kalkanli
Mar 21, 2017·American Journal of Physiology. Heart and Circulatory Physiology·Prasad Srikakulapu, Coleen A McNamara
Jul 16, 2019·Archives of Physiology and Biochemistry·Hamed FouladsereshtMehrnoosh Doroudchi
Apr 2, 2020·Frontiers in Immunology·Sara MandatoriAntonio Filippini
Nov 14, 2019·Journal of Clinical Medicine·Dimitry A ChistiakovAlexander N Orekhov
Oct 4, 2017·Frontiers in Physiology·Prasad SrikakulapuColeen A McNamara
Jun 15, 2019·Annals of Vascular Surgery·Aurore DanvinBlandine Maurel
Oct 15, 2020·Immunology Letters·Fengge WangYuekang Xu
Jul 15, 2021·Vascular·Jingsong CaoJianghua Liu
Jul 30, 2021·Arteriosclerosis, Thrombosis, and Vascular Biology·Dalia E GaddisCatherine C Hedrick
Jul 13, 2021·The Journal of Biological Chemistry·Chen ChengYongning He
Aug 13, 2021·Immunotherapy·Jorge H Tabares-GuevaraJuan C Hernandez

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.